The Ty1 element of the yeast Saccharomyces cerevisiae is a 6-kb retrotransposon with long terminal repeats (LTRs) at each end (10) . Transcription of the element produces an RNA molecule from which the element-encoded proteins TYA and TYB are translated. These proteins are functional homologs of retroviral Gag and Pol proteins, respectively. The TYA and TYB proteins assemble into structures termed virus-like particles (VLPs) because of their similarity in structure to retrovirus core particles. These VLPs are intermediates in transposition within which reverse transcription occurs (17) . During the assembly process, the Ty1 RNA is packaged within the VLPs and subsequently reverse transcribed into a full-length cDNA. In the final step of transposition, the cDNA is integrated into a new site in the host genome, and the cycle begins again with transcription of the element.
Retroviruses and LTR retrotransposons share the problem of having to generate a full-length cDNA from a message that initiates and ends within the LTRs of the element (diagrammed in Fig. 1 ). This is accomplished by initiating reverse transcription near the 5Ј end of the element, immediately next to the LTR, in a region termed the primer binding site (PBS). This produces a short DNA, termed minus strong-stop DNA, part of which is complementary to the 3Ј end of the RNA within the repeat (R) region. The minus-strong stop DNA is transferred to the 3Ј end of the RNA, where it serves as the primer for more extensive minus-strand synthesis.
The reverse transcriptases (RTs) of retroviruses and LTR retrotransposons use host-encoded tRNAs as primers for synthesis of minus strong-stop DNA. The particular tRNA used varies according to the particular retroelement. Ty1 and Ty3 use the tRNA i Met as a minus strong-stop primer (14, 24) . The tRNA i Met is specifically packaged by an unknown mechanism into Ty1-VLPs. For Ty1 it has been shown that the priming tRNA i
Met is 10-to 40-fold enriched in VLPs compared with the cytoplasmic levels of this tRNA (14, 32) . The last 10 nucleotides of the acceptor stem of tRNA i Met are complementary to the Ty1 PBS (Fig. 1 ). This complementarity allows tRNA i Met to prime synthesis of minus strong-stop DNA.
Little is known about what sequences and structural features of the tRNA are important for recognition by RT. Experiments with purified human immunodeficiency virus type 1 (HIV-1) RT and in vitro-synthesized tRNA 3 
Lys
, the primer for HIV, suggest that in this element, RT interacts with the anticodon and T⌿C arms of the primer tRNA (6) (7) (8) . In vivo studies of the effect of primer tRNA mutants on retrovirus multiplication or retrotransposition are complicated by the presence of the wildtype primer tRNA, encoded by multiple genes, in the genome of the host cell. However, using the yeast Ty1 element, we have developed a system in which any mutant tRNA can be tested in vivo for its ability to support transposition. A yeast strain in which all four genomic copies of the tRNA i Met gene (IMT1 to IMT4) have been disrupted has been constructed (37) . Cell growth is supported by an IMT gene on an extrachromosomal plasmid in such strains. A mutant tRNA i Met , encoded by imt4-9, which lacks complementarity to the PBS was constructed. This mutant tRNA i Met can thus no longer prime Ty1 or Ty3 reverse transcription but is still capable of initiating protein synthesis (14, 24) . Thus, a cell expressing exclusively imt4-9 shows no obvious growth defect yet is unable to support Ty1 transposition. This strain can then be transformed with any imt mutant of interest, and the effect on Ty1 or Ty3 transposition can be measured. Importantly, this system does not require the mutant tRNA i Met to be translationally competent; i.e., the tRNA does not have to maintain the ability to initiate translation due to the effects of the mutations on interaction with the synthetase, initiation factors, or ribosomes.
Genetic analyses of the determinants that are important for the translational identities of initiator and elongator tRNA Met have been carried out (4, 37) . Substitution mutations that introduce the corresponding base from the elongator tRNA gene (EMT) were made throughout an IMT gene at the nucleotide positions that are specifically conserved among eukaryotic cytoplasmic initiator tRNAs. Mutation of the A ⅐ U base pair at positions 1 and 72 in the acceptor stem and a double mutation at nucleotides 54 and 60 were deleterious to cell growth (37) . Using the assay systems described here, we show that the acceptor stem and T⌿C arm of tRNA i Met contain bases that are also critical for Ty1 and Ty3 retrotransposition. Mutations throughout the anticodon arm have only minimal effects on transposition of these elements. We demonstrate that disruption of single primer/PBS base pairs (A-C mismatches) between the 3Ј acceptor stem region of tRNA i Met and the PBS can have severe effects on transposition, indicating that primer/ template complementarity is required. However, G-U mismatches at the same positions are quite well tolerated. Finally, we have constructed hybrid initiator tRNA molecules and used them as probes of molecular requirements for retrotransposition. Studies of these hybrid tRNAs implicate yet another determinant for Ty transposition in the D arm of the tRNA.
MATERIALS AND METHODS
Yeast strains. Yeast strains were maintained according to standard techniques, and media were prepared as described previously (34) . SC-X is synthetic complete medium lacking any combination of supplements (X) as indicated by the following abbreviations: adenine, Ade; histidine, His; lysine, Lys; uracil, Ura; tryptophan, Trp; and leucine, Leu. SC-6 is synthetic complete medium lacking adenine, histidine, lysine, uracil, tryptophan, and leucine. Plates contained glucose (2%) as the carbon source except as indicated otherwise (e.g., galactose, also added to 2%). Yeast transformations were done by the lithium acetate method (36). 5-Fluoro-orotic acid medium was prepared as described previously (11) .
The parental yeast strains used in this study are listed in Table 1 . JKc118, the strain transformed with the panel of IMT mutants, was constructed as follows. Strain JB1052 was derived by making strain KC66 (14) his3⌬200 with plasmid YRp14-his3⌬200, using the two-step integration and excision disruption procedure (38) . JB1052 was then transformed with pKC72 (a 2m URA3 plasmid containing the translationally competent imt4-9 gene), generating strain JKc108. The resident YEp351-IMT2 plasmid was then lost by growth on rich medium, resulting in strain JKc118. This strain was then transformed with each of the IMT4-containing plasmids shown in Table 2 . To test whether a given tRNA could function in initiation, the strain was patched onto YPD and then replica plated to 5-fluoro-orotic acid medium. Growth on this medium indicated that the URA3 plasmid (carrying the imt4-9 gene) was lost and that the tRNA gene carried on the LEU2 plasmid was initiating translation.
In subsequent experiments, JB1052 was further modified. To improve galactose induction, it was made Gal ϩ by using the GAL2 plasmid pAA1, generating JKc314. This strain was then made ade2-BglII by using plasmid R943 (19) (the kind gift of S. Roeder), resulting in JKc543. The ade2 auxotrophic marker allows the imt4-9 gene to be maintained on an ADE2 plasmid separate from the Ty1-containing plasmid. Both modifications were made by using the two-step integration and excision disruption procedure (38) . JKc543 was then transformed with pGTy1-H3mhis3AI and pJK207, generating JKc606. The resident YEp351-IMT2 plasmid was then lost by growth on SC-Ura-Ade medium, resulting in strain JKc608. This Leu Ϫ strain was then transformed with the hybrid tRNA plasmids. To test whether a given tRNA could function in initiation, the yeast strain was streaked onto YPD medium and grown for 2 days at 30ЊC. If the tRNA gene on the LEU2 plasmid could support translation, the imt4-9/ADE2 plasmid would be lost at some frequency. Since ade2 mutants of S. cerevisiae accumulate red pigment on YPD medium, the appearance of red-sectored colonies indicated that the tRNA gene carried on the LEU2 plasmid could initiate translation (i.e., the ADE2 plasmid carrying imt4-9 was not essential). To assess transposition in the absence of imt4-9, pJK207 was lost by growth on SC-Ura-Leu medium, and the resulting Ade Ϫ strain was then transformed with the ADE2 vector pJK204. For the PBS mutation experiments, the yeast strain needed to be spt3 to prevent transcription of endogenous Ty1 elements (39) . The SPT3 gene is required for transcription of endogenous Ty1 elements. Transcription of plasmidborne elements under galactose regulation is unaffected by the SPT3 gene product. Thus, JKc314 was made spt3-101 with pFW33, using the two-step integration and excision gene disruption procedure (38) . The resulting strain, JKc348, was transformed with pKC72 and the resident YEp351-IMT2 plasmid was lost by FIG. 1. Priming of reverse transcription in Ty1. DNA is represented as a box, RNA is represented as a solid black line, and LTR sequences are represented by filled triangles. The PBS region is indicated. The Ty1 RNA has 10 nucleotides with complementarity to the 3Ј acceptor stem of the yeast tRNA i Met molecule. The Ty1 RNA and the tRNA molecule can thus form a duplex, which primes synthesis of minus strong-stop DNA (dashed arrow). A mutant tRNA (imt4-9) has been constructed in which the complementarity to the PBS was disrupted, such that it cannot prime reverse transcription from a wild-type PBS (14) . However, the structure of the acceptor stem has been maintained so that this tRNA can function in translation. The sequence of the tRNA molecule is shown at the bottom; nucleotides that were mutated to construct imt4-9 are indicated. Met and acceptor stem mutant-containing plasmids. pKC72 was then replaced by plasmids containing a PBS mutation by loss of pKC72 on SC-Leu medium and transformation with the PBS mutation plasmids.
To assess the effects of tRNA mutations on Ty3 transposition, strain JKcX89-3B was made ade2-BglII (by using plasmid R943 as described above) and subsequently transformed with pEGTy3 (a GAL-Ty3 URA3 plasmid), pCH2bo19V (the transposition target plasmid, HIS3), and pJK207 (imt4-9 ADE2), generating strain JKc654. The panel of tRNA mutant LEU2 plasmids was then transformed into this strain after loss of YEp351-IMT2 (LEU2 IMT2) by growth on SC-UraAde-Trp-His.
DNA plasmids. The plasmids used in this study are listed in Table 2 . Plasmids were prepared by the boiling minipreparation method (23) or by CsCl gradient purification. The details of plasmid construction are contained in the references given in Table 2 or are described below.
pKC72 was constructed by filling in the ends of the 170-bp BamHI-HindIII fragment from pKC10 (containing imt4-9) and ligating it into the unique EagI site of plasmid pGTy1-H3mhis3AI. To construct the ADE2 2m plasmid pJK204, pL909 (a LEU2 ADE2 2m plasmid) was partially digested with PstI and religated, and Leu Ϫ transformants were selected. Then the XbaI-HindIII (filled-in) fragment from pKC10 was cloned into the ClaI (filled-in)-NheI sites of pJK204 to make plasmid pJK207.
Mutagenesis. Phage and plasmid DNAs were altered by site-directed mutagenesis as described previously (27) . For plasmid mutagenesis, helper phage R408 (35) was used for production of single-stranded DNA. Plasmids pKC74 to pKC81 were constructed as follows. KCf2, containing the IMT4 gene in M13mp18, was constructed as described elsewhere (14) . The tRNA anticodon mutants were made as described previously (27) as specified by the Bio-Rad Mutagene kit protocol, using the following oligonucleotides: pKC74, oligonucleotide JB213 (5Ј GGACATCAGGGATATGAGCCCTG); pKC78, oligonucleotide JB214 (5Ј GACATCAGGGTAATGAGCCCTGC); pKC75, oligonucleotide JB215 (5Ј ACATCAGGGTTGTGAGCCCTGCG); pKC80, oligonucleotide JB216 (5Ј CATCAGGGTTAGGAGCCCTGCGC); pKC81, oligonucleotide JB217 (5Ј ATCAGGGTTATCAGCCCTGCGCG); pKC76, oligonucleotide JB218 (5Ј TC AGGGTTATGTGCCCTGCGCGC); and pKC77, oligonucleotide JB219 (5Ј CA GGGTTATGACCCCTGCGCGCT).
Mutant phage were identified by sequence analysis. The deletion mutation in pKC79 was a fortuitous mutant identified during screening by sequencing. The mutant tRNA plasmids were then constructed by ligating the 200-bp BamHIHindIII fragment from a phage replicative-form DNA preparation into the BamHI-HindIII sites of YEp351.
The Ty1 PBS mutation in pJK177 (PBS A 5 to G) was made by site-directed mutagenesis of phage fVIT30 (28), using oligonucleotide JB395 (5Ј ACCGAAG CACAGGCGCCACCATGAGAATT). A 500-bp XhoI-HpaI fragment from a replicative-form preparation of the mutated phage clone was used to replace the corresponding fragment of pKC72. The Ty1 PBS mutation in pJK180 was made by using the 1,554-bp XhoI-BstEII fragment from pVIT61 to replace the corresponding fragment of pKC72. An Arabidopsis thaliana gene encoding tRNA Met gene was cloned into the EcoRV site of pBS(SK)ϩ. The gene was mutated to replace the native acceptor stem with the S. cerevisiae sequence by using oligonucleotides JB695 (5Ј TTTACAACCACGA GCGCCGTAGGAGAGTGG) and JB696 (5Ј CGAAACCTGGCGGCGCTAG TATTTTTTACC). The 240-bp HindIII-BamHI fragment containing the mutated tRNA gene was then subcloned into YEp351 to make pJK258. The 240-bp HindIII-BamHI fragment from the pBS vector containing the unmutated tRNA gene was subcloned into YEp351 to make pJK260.
Transposition assays. For Ty1 transposition assays, strains were patched onto SC-Ura-Leu-Trp or SC-Ura-Leu-Trp-Ade glucose plates and grown for 2 days at 30ЊC. The patches were then replica plated to SC-Ura-Leu-Trp or SC-Ura-LeuTrp-Ade galactose plates and incubated for 1 to 2 days at 22ЊC. Finally, the patches were replica plated to SC-His glucose plates and incubated for 1.5 days at 30ЊC. For quantitative assays, cell patches (ϳ2 cm 2 ) were scraped from the galactose plates into 10 ml of H 2 O and diluted 1/100 in H 2 O. One hundred microliters of the diluted cell suspension was plated onto YPD medium to determine the total number of viable cells in the suspension; 100 l of the undiluted cell suspension (generally 3 ϫ 10 4 to 6 ϫ 10 4 cells) was plated onto SC-His glucose plates and incubated for 2 days at 30ЊC. Transposition is expressed as the number of His ϩ yeast colonies/total cells plated (number of colonies on the YPD plate ϫ dilution factor). The frequency of transposition with a wild-type IMT gene was generally 0.5 to 1%.
The Ty3 transposition assay used has been described elsewhere (24, 26) . For this assay system, we used a specialized Ty3 target plasmid (pCH2bo19V) in which Ty3 integration would activate expression of a previously silent suppressor tRNA gene (Ty3 integrates just upstream of polymerase III transcription initiation sites). This plasmid actually contains two divergent tRNAs, the suppressor tRNA, sup2bo, and a tRNA Val , separated by a 17-bp polypyrimidine tract upstream of the suppressor. Polymerase III does not initiate well in the polypyrimidine context such that sup2bo is expressed at very low levels, as indicated by the inability of sub2bo in this context to suppress ochre mutations in the genomic auxotrophic marker lys2-1o. Thus, yeast strains containing this marker are unable to grow on medium lacking lysine. When this plasmid is present in a strain containing an active Ty3 element, the tRNA Val targets integration to the sup2bo initiation site. The inserted Ty3 sequences allow sup2bo to be expressed. This event is followed by selecting for the suppression of the ochre mutation in lys2-1o. In this system, a Ty3 element regulated by an inducible galactose promoter is present on a separate plasmid. Thus, following galactose induction, transposition is monitored by the frequency of lysine prototrophs. Yeast strains to be tested for transposition were patched onto SC-Ura-His-Leu-Trp-Ade medium. After 1 to 2 days, the patches were replica plated onto SC/galactose-UraHis-Leu-Trp-Ade medium and incubated for 2 days at 22ЊC to induce transposition. Finally, the patches were replica plated onto SD medium and incubated for 7 days at 30ЊC.
RESULTS
Genetic assay. We have developed a system in which any mutant tRNA i Met can be tested in vivo for its ability to support Ty1 transposition. The assay system uses a strain in which all four genomic copies of IMT have been disrupted by TRP1 (37) . The only functional IMT gene present in these cells is supplied on an extrachromosomal plasmid. A key to this system is that any imt mutation can be tested for its ability to support Ty1 transposition, regardless of its ability to function as an initiator tRNA. This was accomplished by constructing a mutation, imt4-9, in which the complementarity between the tRNA acceptor stem and the Ty1 PBS has been disrupted (Fig. 1) . It has previously been demonstrated that whereas imt4-9 will not support transposition, it can initiate translation effectively; thus, a strain relying solely on imt4-9 grows readily (14) .
The strain genotype and plasmids used in the transposition assay are diagrammed in Fig. 2 . The imt4-9 gene was subcloned onto a URA3 2m plasmid containing a marked Ty1 element under control of the inducible galactose (GAL1) promoter ( Fig. 2A) . As this plasmid, pKC72, must be present in the cell at all times to support translation, a Ty1 marker gene which is not expressed from the plasmid but is expressed if transposed into the host genome was used (15) . This marker gene, mhis3AI (Fig. 2B) , was constructed by cloning the HIS3 gene into Ty1 in the reverse orientation of Ty1 transcription. Inserted into the HIS3 coding region is an artificial intron with splice donor and acceptor sites in the same transcriptional orientation as Ty1. The mhis3AI gene carries a HIS3 promoter but produces an inactive protein due to the inserted intron. Induction of Ty1 transcription in galactose-containing medium produces a Ty1 mRNA containing an intron, which is subsequently spliced out. This RNA now contains, at the 3Ј end, antisense HIS3 RNA. If this RNA is successfully reverse transcribed and integrated into the genome, a functional HIS3 gene is formed.
Mutant tRNAs (imt4-x in Fig. 2A ) to be tested for the ability to function for transposition were cloned onto a LEU2 2m plasmid and transformed into the tester strain, JKc118 (Table  1 ). This strain carries the plasmid pKC72, which bears imt4-9 and the pGTy1-H3-mhis3AI construct. The resulting transformants were then assayed for Ty1 transposition as described in Materials and Methods. Typical results for several mutants, as well as the positive and negative control strains, are shown in Fig. 2C . The presence of a wild-type IMT4 gene (positive control) gives confluent growth on selective media, while imt4-9 (negative control) yields only a few His ϩ papillae. Growth on medium lacking histidine is completely dependent on galactose induction of the marked Ty1 (Fig. 2C) .
IMT4 mutants. We tested a panel of tRNAs with mutations in nucleotides known to be important in distinguishing the functions of tRNA i Met and the elongator tRNA (tRNA e Met ) together with a series of mutations in the anticodon region. The tRNA mutants tested in this system and the levels of transposition relative to the wild-type level are listed in Table  3 ; all of these mutants accumulate normal or near-normal levels of tRNA i Met , as determined by RNA blotting using an oligonucleotide probe specific for the IMT4 gene product and its mutant derivatives (data not shown). A diagram of the tRNA i Met indicating the positions mutated (numbered) is shown in Fig. 3 . Control strains contain either IMT4 (positive) or imt4-9 (negative) on the LEU2 plasmid.
A mutation in the D loop had little or no effect on transposition. The imt4-ϩA17 insertion mutation enlarges the D loop by one nucleotide, making it conform to the size of all elongator tRNAs. The crystal structure (9) of tRNA i Met shows that the shorter D loop of initiator tRNAs shortens the backbone of the tRNA molecule, forming part of a T⌿C loop/D-loop connecting structure unique to tRNA i Met . Inserting this nucleotide back into the D loop (imt4-ϩA17) had no effect on transposition.
The anticodon region has been suggested to play a role in the binding of HIV RT (7) . Thus, we introduced transversion mutations throughout the anticodon arm; many of these result in the loss of function of the tRNA for initiation of protein synthesis. These mutations have various effects on Ty1 transposition, but none are severe (Table 3 ; Fig. 2C ). imt4-C35 and imt4-G32 exhibited transposition frequencies the same as or slightly higher than that of the wild-type IMT4 control. The other anticodon mutations demonstrated decreased activity relative to the wild type, but the lowest was only fourfold reduced. Finally, mutation of the conserved run of G ⅐ C base pairs in the anticodon stem had no effect on transposition.
In contrast to mutations in the anticodon region, mutations Met s, is a T (ribothymidine) in virtually all other tRNAs, forming part of the conserved T 54 ⌿C sequence. Mutation of this nucleotide to G (imt4-G54) or C (imt4-C54) causes a 10-fold reduction in transposition frequency. Mutations in A 60 alone (imt4-G60 and imt4-C60) affected transposition but not to the extent of A 54 mutations. Mutation of either A 54 or A 60 alone to uridine extends the length of the T⌿C stem by one base pair, resulting in a very unstable tRNA molecule; thus, the transposition-defective phenotype of these mutants is difficult to interpret (data not shown). A 54 /A 60 double mutations had a very severe effect, reducing transposition frequency to background levels (Table 3 ; Fig. 2C ). A 64 of tRNA i
Met is modified to 2Ј-O-ribosylated adenosine, a modification unique to tRNA i
Met from fungi and plants (16, 21) . Mutation of the U 50 ⅐ A 64 base pair by switching the nucleotide positions (imt4-U64,A50) has only a modest effect on transposition frequency (61% of the wild-type level). However, changing the 50 ⅐ 64 base pair from U ⅐ A to G ⅐ C, thereby placing a pyrimidine at position 64 (imt4-C64,G50), reduces transposition about fivefold compared with the wild type. This modification has been shown to be a critical structure in preventing the tRNA i Met from functioning as an elongator in vitro (25) and in vivo (5) , and the results presented here suggest that it may play a role in tRNA primer function as well.
Acceptor stem mutants. Certain mutations in the acceptor stem abolish transposition. imt4-G1,C72 and imt4-U3,A70 ex- Met present in these cells is supplied by extrachromosomal plasmids. The LEU2 plasmid carries the mutant tRNA of interest. Plasmid pKC72 carries a Ty1 element which allows transposition to be induced on galactose-containing medium and the imt4-9 tRNA gene for supporting cell growth. The Ty1 element is marked, such that transposition is followed by transposition of the marker gene into the yeast genome. As the imt4-9 tRNA gene must be present in the cell at all times to support translation, the Ty1 marker gene used was mhis3AI, which is not expressed when on the plasmid but is expressed if transposed into the host genome (15) . wt, wild type. (B) Diagram of the marker gene mhis3AI. The HIS3 gene is inserted into Ty1 in the reverse orientation of Ty1 transcription. Inserted into the HIS3 coding region is an artificial intron with splice donor (SD) and acceptor (SA) sites in the same transcriptional orientation as Ty1; this gene is termed mhis3AI. The mhis3AI gene carries a HIS3 promoter but produces an inactive protein due to the inserted intron. Induction of Ty1 transcription in galactose-containing medium produces a Ty1 mRNA containing an intron, which is subsequently spliced out. This message now contains, at the 3Ј end, antisense message for HIS3. If this message is successfully reverse transcribed and integrated into the genome, a functional HIS3 gene is formed. (C) Representative transposition assay. Yeast strains, each containing a mutant tRNA gene, are grown on SC-Ura-Leu medium. The imt4-notation indicates which mutant is represented by that patch. The cells are then replica plated to SC galactose-Ura-Leu medium to induce Ty1 transposition. Finally, the cells are replica plated to SC-His medium to select for growth of cells in which the mhis3AI marker has been successfully transposed into the genome. Thus, the amount of growth on SC-His medium correlates with the level of transposition. Growth on SC-His medium depends on galactose induction of the marked Ty, as indicated by the lack of growth of the positive control (IMT4) when the galactose induction step is omitted.
hibited no detectable transposition activity. Both of these mutations, which retain full base pairing in their acceptor stems, are competent for translation. Although these mutations disrupt one base pair of the tRNA/Ty1 PBS helix, the remaining nine positions are complementary. Thus, it was surprising that these mutations had such a severe effect on transposition. We wanted to determine whether the severity of these acceptor stem mutants could be attributed simply to the lack of complementarity to the PBS. If the nucleotide sequence of the acceptor stem contains a critical recognition determinant(s) for something other than the PBS, then restoring complementarity to the PBS is not expected to rescue transposition. However, if the actual nucleotide sequence is irrelevant, and the RT enzyme requires only tRNA/PBS complementarity, then compensatory mutations in the Ty1 PBS region which restore tRNA/PBS complementarity will rescue transposition. The results of this experiment are shown in Fig. 4 . In both cases, compensatory mutations restored transposition to near-wildtype levels. Thus, a single mismatch between the tRNA primer and the Ty1 PBS is sufficient to reduce transposition to undetectable levels.
Interestingly, some mismatched tRNA/PBS pairs show an intermediate level of transposition. Examination of the sequence shows that at two separate positions in the primer/PBS the presence of a G-U mismatch allows for near-wild-type transposition frequencies, while a C-A mismatch abolishes transposition. The mutations in the Ty1 PBS compensating for mutations at position 72 in the tRNA change the amino acid sequence of the TYA protein. Thus, the lower level of transposition in these mutants is probably due to the amino acid change.
Hybrid tRNA molecules as primers. The initiator tRNAs of Schizosaccharomyces pombe and A. thaliana can complement the imt1-4::TRP1 disruption in S. cerevisiae (i.e., expression of these heterologous tRNA i Met s allowed the IMT4 URA3 plasmid to be shuffled out) (13) . Thus, the native tRNA i Met s of both species could serve as effective initiators, as indicated by growth comparable to wild-type growth on glucose medium in the absence of imt4-9 (Fig. 5B) . Neither of these heterologous tRNAs, however, could serve as a primer for retrotransposition (Fig. 5C) . Thus, we wondered whether these initiator tRNAs, if given an acceptor stem complementary to the PBS, would be able to support Ty1 transposition. For this experiment, the tester yeast strain was modified. The strain was made ade2-BglII so that the imt4-9 gene could be maintained on an ADE2 plasmid separate from the Ty1 plasmid (Fig. 5A) . When the acceptor stem of the A. thaliana tRNA i
Met was mutated to match the S. cerevisiae sequence, the resulting hybrid tRNA showed a low level of transposition activity in the presence of imt4-9 (Fig. 5C ). Since this hybrid tRNA itself can serve as an initiator in S. cerevisiae, the imt4-9 plasmid could be shuffled out of this strain. In the absence of imt4-9, this tRNA supports 
17 ϩ a Some previously described mutant tRNAs are actually based on a parental hybrid tRNA consisting of a combination of IMT2 and IMT4 flanking sequences (37) . For simplicity, we have referred to all these sequences as imt4 derived.
b ϩ/Ϫ indicates that the mutant is capable of supporting growth by itself, but Ade Ϫ sectors arise at a very low frequency relative to a wild-type IMT gene or imt mutants indicated by ϩ. See also reference 37.
c Relative transposition frequency is indicated as follows: ϩϩϩ, full activity, comparable to transposition in presence of wild-type IMT4; ϩϩ, transposition activity present but less than that seen with wild-type IMT4; ϩ, transposition activity present but at a level at least fivefold reduced compared with wild-type transposition; ϩ/Ϫ, transposition activity slightly above background; Ϫ, background level (i.e., no detectable transposition). d Not tested for tRNA level by Northern (RNA) blotting.
a high transposition frequency (Fig. 5C ). This result demonstrates that the imt4-9 and hybrid tRNA molecules are competing for an essential factor (presumably Ty1 encoded) for retrotransposition. In contrast to the A. thaliana hybrid tRNA, the Schizosaccharomyces pombe tRNA i Met with an IMT acceptor stem sequence is unable to support transposition of Ty1, even in the absence of imt4-9. A sequence comparison of native S. cerevisiae tRNA i
Met and the two hybrid tRNAs is shown in Fig. 5D , and a graphical compilation of the sequences is shown in Fig.  5E . The nucleotides likely to be most important are those which are similar between S. cerevisiae and A. thaliana but differ in Schizosaccharomyces pombe (boxed in Fig. 5D and E) . These nucleotides cluster in the D arm, suggesting that a determinant important for primer function is located in this region.
Effects of tRNA mutants on transposition of Ty3. The Ty3 retroelement of S. cerevisiae also uses tRNA i Met as the primer for minus strong-stop DNA synthesis (24) . Therefore, the panel of tRNA mutants was tested for transposition in a Ty3 assay system. As summarized in Table 3 , the same mutations which reduce transposition of Ty1 also affect the transposition of Ty3. Although Ty1 and Ty3 are highly divergent elements with marked differences in protein sequence and functional organization, they appear to recognize similar molecular determinants in the tRNA primer.
DISCUSSION
We have developed a genetic system for studying the effects of mutations in the tRNA i Met primer on Ty1 transposition. The priming-deficient imt4-9 gene allows any tRNA mutant to be tested in the absence of a wild-type tRNA i Met . We found that mutations in the T⌿C arm and acceptor stem have the most severe effects on transposition. Additionally, hybrid tRNA molecules implicate an additional determinant in the D stem.
Several studies have addressed the question of what structural features of tRNAs are required for primer function. Barat et al. (7) did in vitro reconstructions of the RT/tRNA 3 Lys complex of HIV with purified virion components. They found that RT binds to its specific primer in the presence of a 100-fold excess of another tRNA. Using cross-linking analysis, they determined that the RT interaction with tRNA occurs in the heavily modified anticodon domain. In a subsequent study (6) , synthetic tRNA was used to study this interaction by introducing mutations into the synthetic tRNA. By using competition studies, it was found that in vitro-synthesized tRNA, which lacks modified bases, had reduced affinity for RT. Furthermore, mutations introduced into the anticodon loop had little effect on the affinity of synthetic tRNA for RT. The authors concluded that the overall structure but not the sequence of the anticodon loop of the tRNA is important for recognition by HIV RT and that modified bases in this region contribute to the stability of the RT/tRNA complex.
Using our in vivo system, we analyzed mutations throughout the anticodon region of tRNA i Met in vivo and found very mild effects on transposition. Thus, the anticodon does not appear to contain a major recognition determinant for Ty1 transposition, even though most of the anticodon mutations were, as expected, translationally defective (Table 3 ). In the HIV in vitro system, tRNA affinity was reduced 100-fold, presumably because of the lack of modifications in the anticodon region. It is possible that modifications in the anticodon loop of tRNA i
Met are required for primer function, although this seems unlikely since only a single base in the anticodon arm is modified (A 38 ), and mutation of A 38 to U had little effect on transposition. Alternatively, Ty1 and HIV, which have extremely different RT primary sequences, may recognize different determinants on their respective tRNA primers.
We have found that mutations in the T⌿C loop at nucleotides 54, 60, and 50/64 affect transposition frequency. As these T⌿C-arm mutations do not affect base pairing to the PBS, they presumably affect a determinant removed from the active priming site of RT. In the L-shaped three-dimensional tRNA structure, the T⌿C and D loops are brought into close proximity. In a nuclease footprinting study of HIV-RT/tRNA 3 Lys complexes, Wöhrl et al. (40) found that these D/T⌿C loop interactions were disrupted by RT binding. The crystal structure of tRNA i
Met from S. cerevisiae indicates that tertiary hydrogen bonding occurs between nucleotides within these loops, forming a D/T⌿C loop substructure that is unique to eukaryotic initiator tRNA (9) . Given these results, it is possible that mutations in the T⌿C loop disrupt an RT recognition determinant. However, we have no direct evidence that the defect is at the level of RT interaction; these mutations may interrupt critical interactions with other Ty1 proteins or with Ty1 RNA. Prats et al. (33) presented evidence suggesting that the NC finger proteins of murine leukemia virus and Rous sarcoma virus position the primer tRNA onto the PBS, and Leis and colleagues have proposed that more extensive tRNA/ viral RNA structures may be important for priming (1, 2, 29) (discussed below). Experiments are in progress to isolate mu- FIG. 4 . Mutations in the acceptor stem are rescued by compensatory mutations in the Ty1 PBS. tRNA mutations in the acceptor stem region have a very severe effect on transposition (Table 3) . Compensatory mutations of the Ty1 PBS at the nucleotides positioned for pairing in the primer template complex restored transposition to wild-type (wt) levels. The compensatory mutation to the mutation at tRNA position 72 did not rescue as well, presumably because this mutation changes the amino acid sequence of the TYA protein (the affected codon is bracketed). The wild-type tRNA gene in combination with PBS mutants gave higher levels of transposition, presumably because these result in G ⅐ U base pairs between the primer and the PBS.
VOL. 15, 1995 INITIATOR tRNA AND Ty1 TRANSPOSITION 223 tations in Ty1 which can suppress the mutant imt4-G54 to determine the detailed nature of these interactions. tRNA i Met in plants and fungi has a unique 2Ј-O-ribosylated backbone modification at purine 64. Some mutations at this position reduce Ty1 transposition frequency. The gene for the modifying enzyme has been cloned, and interestingly, imt mutations in nucleotides 54 and 60 reduce the ability of the tRNA to be modified (5) . As demonstrated here, these same mutations reduce Ty1 and Ty3 transposition ( Table 3 ). The role of this unique modification in Ty1 transposition is currently under further study.
Certain single-base-pair mutations in the acceptor stem reduce transposition at least 50-fold. Transposition can be restored with these tRNA mutants by mutating the Ty1 PBS to restore base pairing between the mutant primer and the Ty1 RNA template (see also reference 14). Thus, the actual sequence of the PBS does not determine RT recognition, but proper primer/template complementarity is essential. This result shows that single point mutations in the PBS region can be very detrimental to retrotransposition. However, we found that G ⅐ U base pairing can be used in this interaction with an efficiency nearly comparable to that for G ⅐ C or A ⅐ U base pairing (see also reference 28). Similarly, in a study of primer selection for mutant PBSs of murine leukemia virus, it was found that a G-U mismatch at PBS position 8 (of 18) could be tolerated (30) . G ⅐ U base pairs occur frequently in tRNA molecules and in the secondary structure of larger RNA molecules (e.g., self-splicing introns). Thermodynamic studies indicate that the contribution to helix formation of internal G-U mismatches is similar to that of an A ⅐ U base pair.
Why are the A-C and C-A mismatches between the acceptor stem and the PBS so deleterious to transposition? This may be due simply to thermodynamic effects, which impair formation of the acceptor stem/PBS duplex RNA. Although the Ty1 PBS is shorter than in retroviruses (10 versus 18 nucleotides), the Ty1 assays are done at 22 to 30ЊC, below the predicted melting temperature of the tRNA/PBS complex. Additionally, a rough calculation of the molarity of the tRNA primer within Ty1-VLPs can be made, on the basis of electron microscopy studies that give a mean particle radius of 30 nm (12, 20, 31) . Even if there is only a single tRNA molecule per VLP, the concentration of primer would be approximately 15 M. Such a high concentration of tRNA primer would strongly favor formation of the tRNA/PBS complex and should minimize the effect of a single mismatch on the ability to form the tRNA/PBS helix. Given the fact that A-C mismatches generally cause more helical distortion than G-U mismatches, we speculate that Ty1 RT is unable to prime using such a distorted RNA duplex. Alternatively, the altered base sequence of the acceptor stem could reduce its ability to melt; such melting would have to occur before the tRNA/PBS complex could form. Distinguishing between these possibilities will require establishing assays for each of these steps in the priming process.
In this genetic system, hybrid tRNAs can be used as probes for primer sequence requirements. These tRNAs serve as translational initiators but fail to support retrotransposition. Both the A. thaliana and Schizosaccharomyces pombe initiator tRNA molecules were mutated so that the acceptor stem would be complementary to the Ty1 PBS. The A. thaliana tRNA could support transposition efficiently only in the absence of the S. cerevisiae imt4-9 gene. This finding suggests that the imt4-9-derived tRNA interacts with a factor required for Ty1 transposition and effectively competes for this interaction with the hybrid tRNA.
The observed competition between wild-type and mutant tRNA primers suggests that it might be possible to inhibit the multiplication of retroviruses through overexpression of a competitor mutant tRNA. This would represent a novel antiretroviral strategy.
Interestingly, the Schizosaccharomyces pombe hybrid tRNA could not support transposition, even in the absence of imt4-9. A sequence comparison of these two hybrids with native S. cerevisiae tRNA i Met (Fig. 5C ) identified yet another potential transposition determinant in the D arm of the tRNA.
Experiments are in progress to determine what step(s) of the transposition pathway is affected by the tRNA mutations. An early block would be encapsidation of the tRNA into the VLPs. Several of the mutants described here have been tested for tRNA encapsidation, and none of these mutants, which included transposition-inactivating mutations in the acceptor and T arms, showed an encapsidation defect (data not shown). Thus, the most likely defect is in priming of minus strong-stop DNA synthesis. Assays aimed at determining the level of strong-stop DNA produced indicate that the T⌿C mutations affect priming (data to be published elsewhere). It is also possible that the primer mutations affect later events in the reverse transcription pathway.
We have tested the tRNA mutations for their effects on transposition of an extremely distant relative of Ty1, Ty3. Interestingly, the same tRNA mutations affect the transposition of both elements. Thus, the two elements appear to utilize similar determinants in this primer. The tRNA i Met specificity of these two elements has probably occurred by convergent evolution, as most elements in the Ty3 family of retrotransposons use other tRNA primers.
Another possible effect of primer mutations could be disruption of interaction with a secondary structure of the Ty1 RNA. Several retroviral RNAs can potentially form secondary structures in the 5Ј R/U5 region. A bulge in this structure contains a region of complementarity to the T⌿C loop of the tRNA primer. Aiyar et al. (1) have shown that mutations in U5 which disrupt this complementarity inhibit reverse transcription. Compensatory changes in the primer can complement the defect in vitro. It is possible that the T⌿C mutations which we have described interrupt a similar interaction with Ty1 RNA. Examination of the RNA sequence of Ty1 has not revealed any Our detailed in vivo genetic analysis of the tRNA primer shows that multiple molecular determinants in the tRNA are absolutely critical for efficient retrotransposition. Because LTR retrotransposons like Ty1 have so many similarities to vertebrate retroviruses, it is likely that the same is true for retroviral primer tRNAs. The detailed understanding of these molecular determinants may ultimately allow novel interventive strategies based on manipulation of the tRNA sequence, structure, or modification state to be developed.
